No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Low Risk Prostate Cancer
Clinical trials for patients who are diagnosed with low risk prostate cancer: Patients with a PSA less than 10, Gleason 6 and cancer involves one half of one side of the prostate or less. (Stage 1)
Find Your Trial
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
Promise Registry - All Risk Levels
PROMISE is a nationwide registry of prostate cancer patients with inherited mutations by screening approximately 5,000 participants with a prostate cancer diagnosis. The PROMISE team is studying how these mutations affect patient outcomes.
